Man's sight returns with Advanced Cell's stem cell treatment

05/21/2013 | New Scientist

An experimental stem cell treatment developed by Advanced Cell Technology restored the sight of a man who suffered retinal cell degeneration, according to the company. The patient is part of a trial testing the safety of stem cell-derived retinal pigment epithelial cells in reversing damage caused by dry age-related macular degeneration or Stargardt's macular dystrophy, two common causes of blindness. The vision in the man's affected eye is said to have improved from 20/400 to 20/40.

View Full Article in:

New Scientist

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN